The FY2025-1 Small Business Innovation Research Contract (SBIR) Program solicitation has been posted!
“The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) invite small business concerns (SBCs) to submit research proposals under this Small Business Innovation Research (SBIR) Contract Solicitation. Firms with the capability to conduct research and development (R&D) in any of the health-related topic areas described in Section 12.0, and to commercialize the results of that R&D, are encouraged to participate.”
Please see link above for specific solicitations. Deadline is October 18, 2024
Contract funding is very different from grant funding, and a project needs to be a very (very) good fit to pursue this mechanism. NIAID offers a useful resource to compare differences between grants and contracts – although written specifically for NIAID, these guidelines generally apply across NIH contracts.
Wondering if your company could win non-dilutive funding through an SBIR contract? Have questions about understanding the solicitation details? Reach out today and we will connect you with one of our experts!
- FY2025 NIH SBIR Contract Topics:
NATIONAL INSTITUTES OF HEALTH (NIH)
NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES (NCATS):
Topic 025 Development of a versatile small footprint benchtop device to perform batch evaporation
Topic 026 Scalable Generation of Liver and Brain Organoids Derived from Human iPS Cells.
NATIONAL CANCER INSTITUTE (NCI):
Topic 466 Novel Delivery Systems for RNA-based Cancer Vaccines
Topic 467 Development of Cancer Immunoprevention Agents
Topic 468 Synthetic Microbes (Excluding Oncolytic Viruses) for Immuno-Oncology Therapies
Topic 469 Development of Novel Therapeutics for HPV-related Precancer
Topic 470 Precision Nutrition Interventions to Reduce Cancer-Related Symptoms
Topic 471 Drug-Loaded Carrier Particles for Improved Oral Delivery for Colon Cancer Prevention
Topic 472 Antibody-Drug Conjugates as Radiopharmaceutical Theranostics for Cancer
Topic 473 Point of Care Detection of Antibodies Against HPV16/18 E6 and E7 Oncoproteins in Oropharyngeal Cancer
Topic 474 Point of Care Technologies for GI Cancer Prevention and Early Detection
Topic 475 Development of Digital Biomarkers and Endpoints for Clinical Cancer Care
Topic 476 Digital Twin Software for Optimization of Cancer Radiation Therapy
Topic 477 Wearable Technologies to Facilitate Remote Monitoring of Cancer Patients Following Treatment
Topic 478 Advanced Biomaterials to Improve Cancer Modeling for Research
NATIONAL INSTITUTE ON AGING (NIA):
Topic 011 Digital Technologies as Tools to Screen and Monitor Alzheimer’s Disease (AD) and Related Dementias (ADRD)
Topic 012 Modeling Aging through Microphysiological Systems
Topic 013 Leveraging Multimodal and Generative Artificial Intelligence to Advance the Application of Social Robotics in Caregiving
NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM
Topic 020 Alcohol-activated locking systems for firearms and firearm storage units
Topic 021 Data science tools for accelerating alcohol research
Topic 022 Non-invasive Wearable Alcohol Sensor
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID):
Topic 137 New Drug Classes with Novel Mechanisms of Action for HIV, Hepatitis B, and Tuberculosis
Topic 138 Devices and Materials-Based Platforms for the Delivery of Broadly Neutralizing Antibodies
Topic 139 Rapid Diagnostic Assays for Self-Monitoring of Acute or Rebound HIV-1 Infection
Topic 140 Adjuvant Discovery and Down-Selection for Vaccines against Infectious and Immune- Mediated Diseases
Topic 141 Reagents for Immunologic Analysis of Non-mammalian and Underrepresented Mammalian Models
Topic 142 Adjuvant Development for Vaccines and for Autoimmune and Allergic Diseases
Topic 143 Development of Diagnostics for Mycoplasma genitalium Infection
Topic 144 Development of Medical Interventions for Treating Non-Tuberculosis Mycobacterial (NTM) Infections
Topic 145 Diagnostics to Detect Host Immunity to Coccidioidomycosis (Valley fever) or Histoplasmosis
Topic 146 Discovery and Development of Oral Small-molecule Direct-acting Antivirals Targeting Viruses of Pandemic Potential
Topic 147 Software or Web Services to Assess Quality and Reproducibility of Data and Information about Therapeutics and Vaccines
NATIONAL INSTITUTE OF MENTAL HEALTH (NIMH):
Topic 001 Point-of-Care and Pharmacy-based Antiretroviral Drug Adherence Assays
Topic 002 Development of novel In-vitro and In-vivo Models to support NeuroHIV Research
CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC)
NATIONAL CENTER FOR EMERGING ZOONOTIC AND INFECTIOUS DISEASE (NCEZID):
Topic 032 Canine Vaccines to Prevent Tick Bites
Topic 033 Rapid, Portable, Point-of-Care Carbapenem Resistant Acinetobacter Colonization Screening Diagnostic
Topic 034 Improved Diagnostic Assays for Foodborne and Waterborne Bacterial Pathogens
Topic 035 Improved Diagnostic Assays for Parasitic Diseases
Topic 036 Developing an Over-the-Counter Diagnostic for Valley Fever
Topic 037 Enhancing the CDC Autocidal Gravid Ovitrap to Control Dengue Vectors
NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES (NCIRD):
Topic 038 Development of a Molecular Panel to Detect Febrile Rash Illnesses
Topic 039 Synthetic IgM Antibody Controls for Measles, Mumps, and Rubella Assays
NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL (NCIPC)
Topic 001 Data Science Solutions to Characterize Polysubstance Use Behavior from Online Sources
Webinar resources are now available:
Are you ready to get started on winning the non-dilutive funding your company needs?
Recent Comments